APA (7th ed.) Citation

GJ, B., G, O., A, S., M, M., E, F., A, B., . . . M, M. (2022). Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature. Antibiotics (Basel, Switzerland), 11(8), . https://doi.org/10.3390/antibiotics11081007

Chicago Style (17th ed.) Citation

GJ, Burastero, et al. "Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature." Antibiotics (Basel, Switzerland) 11, no. 8 (2022). https://doi.org/10.3390/antibiotics11081007.

MLA (9th ed.) Citation

GJ, Burastero, et al. "Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature." Antibiotics (Basel, Switzerland), vol. 11, no. 8, 2022, https://doi.org/10.3390/antibiotics11081007.